Scroll up to Strategy

Investments

Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.

AavantiBio
Adagio Therapeutics
Affinivax
Amunix Pharmaceuticals
Amylyx Pharmaceuticals
annexon
Aptinyx Logo
arcutis
atea_logo
c4_therapeutics
Cerevel Therapeutics
constellation
Dicerna
dynavax-Logo
EQRx Logo
freenome
gynesonics
hugel
imperative-care
inflarx
Interius BioTherapeutics
jenavalve
Kestra
kymera
marinus
mersana
Nautilus Biotechnology
nurix-logo
Nuvalent
pharvaris
rapid-micro-biosystems
replimune
River Renal Logo
savara
solid-biosciences
SpringWorks Therapeutics
Synthekine
Syros Pharmaceuticals Logo
Tango Therapeutics
Thrive
 

BCLS Acquisition Corp.

BCLS Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a business combination with one or more biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.

Click here to visit the website.

Strategy Icon

Our team thinks critically about the issues around hard science, clinical trial design, and the regulatory environment in our investment approach.

Scroll down to People
_
_